Raymond James & Associates Cuts Stock Holdings in Trupanion, Inc. (NASDAQ:TRUP)

Raymond James & Associates lowered its stake in Trupanion, Inc. (NASDAQ:TRUP) by 18.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,054 shares of the financial services provider’s stock after selling 4,100 shares during the quarter. Raymond James & Associates’ holdings in Trupanion were worth $551,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Nordea Investment Management AB lifted its position in shares of Trupanion by 247.4% in the fourth quarter. Nordea Investment Management AB now owns 37,268 shares of the financial services provider’s stock worth $1,126,000 after buying an additional 26,540 shares in the last quarter. Liontrust Investment Partners LLP purchased a new stake in shares of Trupanion during the 3rd quarter worth approximately $829,000. Wellington Management Group LLP boosted its position in shares of Trupanion by 5.3% during the 3rd quarter. Wellington Management Group LLP now owns 1,823,530 shares of the financial services provider’s stock valued at $51,424,000 after acquiring an additional 91,895 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Trupanion by 5.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 292,941 shares of the financial services provider’s stock valued at $8,261,000 after purchasing an additional 14,044 shares in the last quarter. Finally, SG Americas Securities LLC increased its position in Trupanion by 103.1% in the fourth quarter. SG Americas Securities LLC now owns 18,819 shares of the financial services provider’s stock worth $574,000 after purchasing an additional 9,551 shares during the last quarter.

Trupanion Stock Down 2.5 %

NASDAQ TRUP opened at $23.31 on Friday. Trupanion, Inc. has a 52 week low of $18.45 and a 52 week high of $37.71. The firm has a market capitalization of $974.59 million, a price-to-earnings ratio of -21.58 and a beta of 1.71. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. The company has a fifty day moving average of $25.67 and a two-hundred day moving average of $26.85.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, February 15th. The financial services provider reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.13. Trupanion had a negative net margin of 4.03% and a negative return on equity of 15.19%. The firm had revenue of $295.50 million during the quarter, compared to analysts’ expectations of $289.84 million. During the same period in the previous year, the company earned ($0.23) EPS. The firm’s revenue for the quarter was up 20.1% compared to the same quarter last year. On average, analysts predict that Trupanion, Inc. will post -0.43 earnings per share for the current year.

Wall Street Analyst Weigh In

TRUP has been the subject of several research reports. Piper Sandler lowered their price objective on shares of Trupanion from $32.00 to $28.00 and set a “neutral” rating for the company in a research report on Friday, April 5th. Evercore ISI lowered their price target on shares of Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a report on Tuesday, February 20th. Finally, Stifel Nicolaus boosted their price objective on Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a research note on Friday, February 16th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Trupanion has a consensus rating of “Hold” and an average price target of $33.20.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.